McDermott DF, Lee J-L, Szczylik C, et al. Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (accRCC): Results from cohort A of KEYNOTE-427. J Clin Oncol 36, 2018 (suppl; abstr 4500).
Video: TheraP-data ondersteunen gebruik Lu-177-PSMA-617 bij mCRPC
feb 2021 | Uro-oncologie